Navigation Links
GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD

The Food and Drug Administration. has given GlaxoSmithKline PLC's anti-seizure medicine to treat Primary Generalized Tonic-Clonic, or PGTC, the green signal.//

According to GlaxoSmithKline, the U.K. pharmaceutical company, the drug, Lamictal, has been approved to treat children age two and older, as well as adults.

PGTC seizures are said to be the most-serious and most-commonly occurring type of generalized seizures, seen in about 20% of patients with epilepsy.

Epilepsy is a recurrent, unprovoked seizure characterized by a change in sensation, awareness, or behavior which comes about by an electrical disturbance in the brain.

Lamictal has now received the fifth FDA approval. It been approved to treat partial and generalized seizures and as well as for use as maintenance therapy for adults with bipolar disorder.

The FDA's approval is said to have been based on a multicenter trial in pediatric and adult patients, which proved to be "highly effective" in reducing the frequency of generalized tonic-clonic seizures by 66%.


NLA
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
2. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
3. Researchers Scale to assess the Severity of Epilepsy in Kids
4. Epilepsy can be predicted
5. Epilepsy Drugs Can Enhance Risk of Birth Defects
6. Epilepsy Drug Helps Diabetic Nerve Damage
7. Epilepsy Drug May Relieve Chronic Headaches
8. More Complications Seen In Women With Epilepsy
9. Epilepsy Drugs Found To Lead To Bone Loss
10. Another Use For Epilepsy Drugs
11. Epilepsy Patients Could Benefit From Pacemakers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... - Cincinnati, Ohio (PRWEB) , ... December 09, ... ... the production of miniature, folded, pharmaceutical inserts and outserts. As a means ... Device. This addition will enable Flottman to individually code professional inserts (PIs) ...
(Date:12/9/2016)... ... December 09, 2016 , ... An inventor from Cana, Va., wanted to fulfill ... of amusement park rides. , The patent-pending SAFETY STRAP FOR AMPUTEES improves accessibility. It ... could be set up in a matter of minutes, or even seconds. The SAFETY ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016  RxWiki Inc., a digital ... digital marketing strategies of thousands of pharmacies through its ... Austin Inno,s "50 on Fire" Award in ... "We,re pleased to accept the award as one of ... Chief Executive Officer at RxWiki. "Our platform gives independent ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
(Date:12/8/2016)... , Dec. 8, 2016 Global Interventional ... on the global interventional radiology market analyzes the ... report comprises an elaborate executive summary, including a ... segments and sub-segments. The research is a ... formed the bulk of our research efforts along ...
Breaking Medicine Technology: